Lisa joined RAPT Therapeutics in 2018, bringing more than 20 years of experience in business and scientific leadership. At RAPT she is responsible for lead asset partnering and out-licensing, having secured a significant partnership with Hanmi Pharmaceutical Co., LTD. Prior to joining RAPT, she served as Director of Alliance Management for Nurix, Inc. where she managed drug discovery and development of strategic alliances with pharma partners in addition to management of strategic research collaborations. Previously, she served as Associate Director of Alliance Management for Novartis Diagnostics managing four commercial alliances as well as establishing cross-functional operating committees to govern product development and commercial activities. Prior to Novartis, she held positions of escalating responsibility at Codexis, Incyte, and Exelixis. She received her Ph.D. in Biology from the Massachusetts Institute of Technology and her B.A. in Biology from the University of California, Santa Cruz.
Sign up to view 1 direct report
Get started